Compiled by Cari Kraft, Jacobs Management Group, Inc.
INDUSTRY TRENDS: BY THE NUMBERS
Amount of healthcare data estimated
to be generated in 2020
Only 153 exabytes (one exabyte = one
billion gigabytes) were produced in 2013.
The growth of this data is predicted to be
at least 48 percent annually.
Source: Stanford Medicine 2017 Health
Trends Report: Harnessing the Power of
Data in Health.
Projected U.S. per-person spending on
medicines through 2022
Per capita spending on medicines is expected to
decline by end of 2018 and stay steady at about
$800 per capita through 2022. Figure is adjusted
for population growth, rising GDP, and estimates
of manufacturer revenue.
Source: IQVIA Institute for Human Data Science,
2018 and Beyond: Outlook and Turning Points,
Percent of Americans uninsured as of 4Q 2017
This figure is down from 16% in 2010, but up from
the low of 10.9% in Q3 2016.
SOURCE: Gallup-Sharecare Wellbeing Index
U.S. brand sales expected to face generic or biosimilar competition
Ninety percent of all prescriptions in the U.S. are filled with generics
today. A report by industry association PhRMA suggests that $105B of
brand sales will face generic or biosimilar competition by 2022.
Source: PhRMA, 2018 Profile: Biopharmaceutical Research Industry